How indoor air purifiers can improve heart failure outcomes
Effectiveness of Indoor Air Purifiers on Heart Failure Outcomes (The PURI-HF Trial)
This study is looking at how using special air purifiers can help people with heart failure feel better and live more comfortably by reducing air pollution in their homes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10665040 on NIH RePORTER |
What this research studies
This research investigates the impact of indoor air purifiers on patients with heart failure, particularly focusing on how reducing air pollution can enhance their daily living functionality. The study will involve participants using high-efficiency particulate air (HEPA) purifiers to see if this leads to better health outcomes, including fewer hospitalizations and improved quality of life. By examining the long-term effects of these purifiers, the research aims to fill gaps in current knowledge about air quality and cardiovascular health. Participants will be monitored for changes in their heart failure symptoms and overall health status.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with heart failure who are exposed to high levels of indoor air pollution.
Not a fit: Patients with heart failure who are not exposed to significant indoor air pollution may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved heart failure management and better quality of life for patients through enhanced air quality.
How similar studies have performed: Previous studies have shown promising results in using air purifiers to improve health outcomes in similar populations, indicating a potential for success in this approach.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Vedanthan, Rajesh — New York University School of Medicine
- Study coordinator: Vedanthan, Rajesh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.